Skip to main content

Advantigen™5.1

New generation pentavalent vaccine developed by Microtek Research and Development Ltd. and distributed in the United States by Maine BioTek, Inc.
Provides protection against furunculosis, vibriosis, cold water vibriosis and winter sores
Product description
- Information sheet Advantigen5.1-insert
- Material Safety Data Sheet MSDSAdvantigen5.1

Vaccines > Advantigen 5.1

Vaccines | Antibodies

Autogenous Vaccines | Advantigen 5.1

Overview of Advantigen ™ 5.1

Protective antigens	Aeromonas salmonicida, Vibrio anguillarum O1, Vibrio anguillarum O2, Vibrio salmonicida, Moritella viscosa inactivated with formaldehyde
Formulation	Water-in-oil adjuvant
Manufacturing	EU-GMP facility
Storage conditions	2º - 7ºC (35º - 45ºF) Use entire contents when first opened. Do not store partially used vaccine bottles.
Licensing	Canada (since May 2005) USA (January 2008)
Method of administration	Intraperitoneal injection
Dose	0.1 mL
Needle size	22-25 gauge
Container size	500 mL; 5000 doses
Target species	Salmonids
Minimum fish size	10 g
Holding period after vaccination	400 degree days*
Slaughter withdrawal time	21 days

Maine Biotek - P.O. Box 408 - 259 Main Street - Winterport, ME04496

Website built & hosted with RainStorm Consulting